(Q45788992)

16 December 2017

title

Use of recombinant interferon-alpha in human immunodeficiency virus (HIV)-infected individuals (English)

1 reference

16 December 2017

author name string

J Rivero

1

1 reference

16 December 2017

M Limonta

2

1 reference

16 December 2017

A Aguilera

3

1 reference

16 December 2017

M Fraga

4

1 reference

16 December 2017

P López Saura

5

1 reference

16 December 2017

publication date

1 January 1994

1 reference

16 December 2017

Biotherapy (Dordrecht, Netherlands)

published in

1 reference

16 December 2017

volume

8

1 reference

16 December 2017

issue

1

1 reference

16 December 2017

page(s)

23-31

1 reference

16 December 2017

Human alpha- and beta-interferon but not gamma- suppress the in vitro replication of LAV, HTLV-III, and ARV-2.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF01878118

Inhibition of human immunodeficiency virus type 1 morphogenesis in T cells by alpha interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01878118

Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01878118

Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01878118

Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01878118

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01878118

Direct and cell-mediated effects of interferon-alpha and -gamma on cells chronically infected with HTLV-III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01878118

21 January 2018

Identifiers

DOI

10.1007/BF01878118

1 reference

16 December 2017

Dimensions Publication ID

1029548892

0 references

1 reference

16 December 2017